IP Library Granted Patent US 7,186,841
Granted Patent B2
US 7,186,841 · App. 10/928,784 · Granted Mar 6, 2007

Antiinflammation agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,841
App. No.
10/928,784
Granted
Mar 6, 2007
Kind
B2
Abstract

Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain fused carbocyclic or heterocyclic rings.

Claims (11)

1. A compound having a formula:

or a pharmaceutically acceptable salt thereof, wherein

W is N;

X id CH;

R 4 is selected from the group consisting of H, (C 1 –C 6 )alkyl, (C 3 –C 6 )cycloalkyl, (C 4 –C 7 )cycloalkyl-alkyl, (C 2 –C 6 )alkenyl and (C 2 –C 6 )alkynyl;

A is a substituted or unsubstituted 6-membered carbocyclic or heterocyclic aromatic ring system, wherein the heterocyclic aromatic ring system contains 1–2 N atoms; and

B is selected from the group consisting of 1-methylimidazol-5-yl, 1-(trifluoromethyl)imidazol-5-yl, 5-methylimidazol-1-yl, 5-(trifluoromethyl)imidazol-1-yl, thiazol-5-yl, imidazol-1-yl, 1-methyl-1,3,4-triazolyl, and 4-methyl-1,2,4-triazol-3-yl,

wherein the B ring is substituted or unsubstituted, and the substituents on B ring, if present, are selected from a group consisting of halogen, CF 3 , CF 3 O, (C 1 –C 6 )alkyl, perfluoro(C 1 –C 6 )alkyl, (C 2 –C 6 )alkenyl, (C 2 –C 6 )alkynyl, (C 1 –C 6 )heteroalkyl, (C 1 –C 6 )alkoxy, (C 1 –C 6 )thioalkoxy, amino, (C 1 –C 6 )alkylamino, di(C 1 –C 6 )alkylamino, (C 3 –C 10 )cycloalkyl, (C 4 –C 10 )cycloalkyl-alkyl, (C 3 –C 10 )cycloheteroalkyl, cyano, nitro, sulfonamido, (C 1 –C 6 )acyl, (C 1 –C 6 )acylamino, (C 2 –C 6 )alkoxycarbonyl, (C 2 –C 6 )alkoxycarbonyl(C 1 –C 6 )alkyl, carboxamido and (C 1 –C 6 )heteroalkoxy.

2. The compound of claim 1 , wherein R 4 is hydrogen.

3. The compound of claim 1 , wherein the compound is selected from:

4. A compound selected from:

Assignments (5)
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →
MERGER Recorded Apr 11, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 015886/0253 →
CHANGE OF NAME Recorded Apr 11, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 015886/0258 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 015886/0273 →